Table 1.
Baseline demographic and clinical characteristics of the patients.
| Demographic information | Pooled Cohorta (n = 242) |
|
|---|---|---|
| Age (years) | 50.8 ± 9.2 | |
| Years of education | 11.2 ± 3.4 | |
| Body mass index (kg/m2) | 24.5 ± 4.3 | |
| Ethnicity | Chinese | 203 (83.9) |
| Malay | 23 (9.5) | |
| Indian | 9 (3.7) | |
| Others | 7 (2.9) | |
| Breast cancer stage | I | 31 (12.8) |
| II | 153 (63.2) | |
| III | 58 (24.0) | |
| ECOG status | 0 | 229 (94.6) |
| 1 | 13 (5.4) | |
| Chemotherapy regimen | Anthracycline-based | 166 (68.6) |
| Taxane-based | 76 (31.4) | |
| Menopausal status | Pre-menopausal | 122 (50.4) |
| Post-menopausal | 120 (49.6) | |
| Estradiol (pM) | 191.9 ± 232.2 | |
| DHEAS (µM) | 2.8 ± 1.9 | |
| DHEA (nM) | 14.5 ± 10.9 | |
| Baseline fatigue scoresb | 1.7 ± 1.8 | |
| Baseline anxiety scoresc | 6.8 ± 6.9 | |
| Baseline insomnia scoresd | 21.7 ± 26.1 | |
aData are presented as mean ± standard deviation for continuous variables and frequency (%) for categorical variables.
bFatigue scores are out of maximum of 10 points, with higher score indicating greater extent of fatigue. cAnxiety scores are out of maximum of 63 points, with higher score indicating greater extent of anxiety. dInsomnia scores are out of maximum of 100 points, with higher score indicating greater extent of insomnia.